Lilly's experimental drug cuts weight by 21% in diabetes trial
来源：Reuters发布于 2026-09-29
Eli Lilly said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.
相关标的：LLY
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。